The DOI matches its Crossref record; 271 of the 271 references it cites were found in a registry or an index.
Intervention strategies to inhibit protein carbonylation by lipoxidation‐derived reactive carbonyls
Abstract
Protein carbonylation induced by reactive carbonyl species (RCS) generated by peroxidation of polyunsaturated fatty acids plays a significant role in the etiology and/or progression of several human diseases, such as cardiovascular (e.g., atherosclerosis, long‐term complications of diabetes) and neurodegenerative diseases (e.g., Alzheimer's disease, Parkinson's disease, and cerebral ischemia). Most of the biological effects of intermediate RCS, mainly α,β‐unsaturated aldehydes, di‐aldehydes, and keto‐aldehydes, are due to their capacity to react with the nucleophilic sites of proteins, forming advanced lipoxidation end‐products (ALEs). Because of the emerging deleterious role of RCS/protein adducts in several human diseases, different potential therapeutic strategies have been developed in the last few years. This review sheds focus on fundamental studies on lipid‐derived RCS generation, their biological effects, and their reactivity with proteins, with particular emphasis to 4‐hydroxy‐trans‐2‐nonenal (HNE)‐, acrolein (ACR)‐, malondialdehyde (MDA)‐, and glyoxal (GO)‐modified proteins. It also discusses the recently developed pharmacological approaches for the management of chronic diseases in which oxidative stress and RCS formation are massively involved. Inhibition of ALE formation, based on carbonyl‐sequestering agents, seems to be the most promising pharmacological tool and is reviewed in detail. © 2006 Wiley Periodicals, Inc. Med Res Rev, 27, No. 6, 817–868, 2007
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–271 of 271
Iron and ferritin in substantia nigra in Parkinson's disease.
Jellinger, K. A., Kienzl, E., Rumpelmaier, G., Paulus, W., Riederer, P., Stachelberger, H., Youdim, M. B. H., & Ben‐Shachar, D. (1993) · PubMed · Cited by 78
Unsaturated aldehydes including 4-OH-nonenal are elevated in patients with congestive heart failure
Mak, S. S., Lehotay, D. C., Yazdanpanah, M., Azevedo, E. R., Liu, P. P., & Newton, G. E. (2000) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(00)90012-5 · Cited by 77
Chemical Modification of Proteins by Lipids in Diabetes
Baynes, J. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.179 · Cited by 77
Kaminskas, L. M., Pyke, S. M., & Burcham, P. C. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.067330 · Cited by 74
Slatter, D. A., Avery, N. C., & Bailey, A. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310608200 · Cited by 73
Role of lipids in chemical modification of proteins and development of complications in diabetes
Januszewski, A. S., Alderson, N. L., Metz, T., Thorpe, S. R., & Baynes, J. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311413 · Cited by 73
The effect of ethanol-induced CYP2E1 on proteasome activity: the role of 4-hydroxynonenal
Bardag‐Gorce, F., Li, J., French, B. A., & French, S. W. (2005) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2004.10.005 · Cited by 72
Aldini, G., Granata, P., & Carini, M. (2002) · Journal of Mass Spectrometry · doi:10.1002/jms.381 · Cited by 71
Self-citationWoltjer, R. L., Maezawa, I., Ou, J. J., Montine, K. S., & Montine, T. J. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5607 · Cited by 70
Isoketals: highly reactive γ-ketoaldehydes formed from the H2-isoprostane pathway
Davies, S. S., Amarnath, V., & Roberts, L. J. (2003) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2003.10.007 · Cited by 69
Aldini, G., Orioli, M., Carini, M., & Facino, R. M. (2004) · Journal of Mass Spectrometry · doi:10.1002/jms.696 · Cited by 67
Self-citationTestosterone increases osteoprotegerin mRNA expression in mouse osteoblast cells.
Chen, Q., Kaji, H., Kanatani, M., Sugimoto, T., & Chihara, K. (2004) · Hormone and Metabolic Research · doi:10.1055/s-2004-826013 · Cited by 67
The antihypertensive hydralazine is an efficient scavenger of acrolein
Burcham, P. C., Kerr, P. G., & Fontaine, F. R. (2000) · Redox Report · doi:10.1179/rer.2000.5.1.47 · Cited by 66
Phosphate Transport in Yeast Vacuoles
Booth, J. W., & Guidotti, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20408 · Cited by 65
Burcham, P. C., Fontaine, F. R., Kaminskas, L. M., Petersen, D. R., & Pyke, S. M. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.655 · Cited by 65
The reaction of some dicarbonyl sugars with aminoguanidine
Hirsch, J., Petráková, E., & Feather, M. S. (1992) · Carbohydrate Research · doi:10.1016/s0008-6215(00)90999-6 · Cited by 64
Five Cysteine-Containing Compounds Delay Diabetic Deterioration in Balb/cA Mice
Hsu, C., Yen, H.-F., Yin, M., Tsai, C.-M., & Hsieh, C.-H. (2004) · Journal of Nutrition · doi:10.1093/jn/134.12.3245 · Cited by 63
HNE––signaling pathways leading to its elimination
Forman, H. J., Dickinson, D. A., & Iles, K. E. (2003) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(03)00013-x · Cited by 62
Chemical modification of muscle protein in diabetes
Alt, N., Carson, J. A., Alderson, N. L., Wang, Y., Nagai, R., Henle, T., Thorpe, S. R., & Baynes, J. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.03.012 · Cited by 62
On the reaction of glyoxal with proteins
Schwarzenbolz, U., Henle, T., Haeßner, R., & Klostermeyer, H. (1997) · Zeitschrift für Lebensmittel-Untersuchung und -Forschung. B, Referate und Lebensmittelrecht · doi:10.1007/s002170050137 · Cited by 59
Chen, J., Robinson, N. C., Schenker, S., Frosto, T. A., & Henderson, G. I. (1999) · Hepatology · doi:10.1002/hep.510290611 · Cited by 58
Advanced Glycation End Products in Clinical Nephrology
Kalousová, M., Zima, T., Tesař, V., Štípek, S., & Sulková, S. (2003) · Kidney & Blood Pressure Research · doi:10.1159/000075533 · Cited by 56
Site-Specific Inactivation of Aldose Reductase by 4-Hydroxynonenal
CORSO, A. D., Monte, M. D., Vilardo, P. G., Cecconi, I., Moschini, R., Banditelli, S., Cappiello, M., Tsai, L., & Mura, U. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0488 · Cited by 55
Miller, A. G., Meade, S. J., & Gerrard, J. A. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00565-5 · Cited by 54
Acrolein Modifies Apolipoprotein A‐I in the Human Artery Wall
Shao, B., O’Brien, K. D., McDonald, T. O., Fu, X., Oram, J. F., Uchida, K., & Heinecke, J. W. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.046 · Cited by 54
Proteomic Analysis of Arginine Adducts on Glyoxal-modified Ribonuclease
Cotham, W. E., Metz, T., Ferguson, P. L., Brock, J. W. C., Hinton, D. J. S., Thorpe, S. R., Baynes, J., & Ames, J. M. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400002-mcp200 · Cited by 53
Paradoxical Impact of Antioxidants on Post-Amadori Glycoxidation
Culbertson, S. M., Vassilenko, E. I., Morrison, L. D., & Ingold, K. U. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305099200 · Cited by 52
The roles of carnosine in aging of skeletal muscle and in neuromuscular diseases.
Stuerenburg, H. J. (2000) · PubMed · Cited by 52
Miyata, T., & de Strihou, C. V. Y. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.010 · Cited by 51
Nakamura, Y., Morimitsu, Y., Uzu, T., Ohigashi, H., Murakami, A., Naito, Y., Nakagawa, Y., Osawa, T., & Uchida, K. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00487-0 · Cited by 48
Miyata, T., Saitō, A., Kurokawa, K., & de Strihou, C. V. Y. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.suppl_4.8 · Cited by 48
Ong, W., Lu, X., Hu, C., & Halliwell, B. B. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00238-0 · Cited by 47
Nyengaard, J. R., Chang, K. C., Berhorst, S., Reiser, K. M., Williamson, J. R., & Tilton, R. G. (1997) · Diabetes · doi:10.2337/diab.46.1.94 · Cited by 45
Inhibition of succinic semialdehyde dehydrogenase activity by alkenal products of lipid peroxidation
Nguyen, E., & Picklo, M. J. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00220-x · Cited by 45
Carnosine protects rats under global ischemia
Stvolinsky, S. L., Kukley, M., Dobrota, D., Mézešová, V., & Болдырев, А. А. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00366-x · Cited by 45
Miyoshi, H., Taguchi, T., SUGIURA, M., Takeuchi, M., Yanagisawa, K., Watanabe, Y., Miwa, I., Makita, Z., & Koike, T. (2002) · Hormone and Metabolic Research · doi:10.1055/s-2002-33478 · Cited by 43
Kang, Z., Li, H., Li, G., & Yin, D. (2005) · Amino Acids · doi:10.1007/s00726-005-0209-6 · Cited by 42
Introduction to serial reviews on 4-hydroxy-2-nonenal as a signaling molecule
Forman, H. J., & Dickinson, D. A. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.06.009 · Cited by 42
Antioxidant therapy for atherosclerotic vascular disease: the promise and the pitfalls
Shihabi, A., Li, W.-G., Miller, F. J., & Weintraub, N. L. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2002.282.3.h797 · Cited by 41
Electron Delocalization in Aminoguanidine: A Computational Study
Bharatam, P. V., Iqbal, P., Malde, A. K., & Tiwari, R. (2004) · The Journal of Physical Chemistry A · doi:10.1021/jp049366e · Cited by 40
Chen, A.-S., Taguchi, T., SUGIURA, M., Wakasugi, Y., Kamei, A., Wang, M., & Miwa, I. (2004) · Hormone and Metabolic Research · doi:10.1055/s-2004-814344 · Cited by 40
Guiotto, A., Calderan, A., Ruzza, P., Osler, A., Rubini, C., Jo, D., Mattson, M. P., & Borin, G. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050507q · Cited by 39
Akhand, A. A., Hossain, K., Kato, M., Miyata, T., Du, J., Suzuki, H., Kurokawa, K., & Nakashima, I. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00702-x · Cited by 38
Beneficial effects of aminoguanidine on the cardiovascular system of diabetic rats
Stadler, K., Jenei, V., Somogyi, A., & Jakus, J. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.501 · Cited by 37
Thérapeutiques anti-oxydantes et anti-AGE : bilans et perspectives
Bonnefont‐Rousselot, D. (2001) · Journal de la Société de Biologie · doi:10.1051/jbio/2001195040391 · Cited by 35
Mitchell, A. E., Morin, D., Lamé, M. W., & Jones, A. D. (1995) · Chemical Research in Toxicology · doi:10.1021/tx00050a009 · Cited by 34
Correction for Ho et al., Isolation of anti-CD22 Fv with high affinity by Fv display on human cells
(2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707408104 · Cited by 34
Inhibitory effect of metformin on formation of advanced glycation end products
Tanaka, Y., Iwamoto, H., Onuma, T., & Kawamori, R. (1997) · Current Therapeutic Research · doi:10.1016/s0011-393x(97)80103-8 · Cited by 33
Noiri, E., Yamada, S., Nakao, A., Tsuchiya, M., Masaki, I., Fujino, K., Nosaka, K., Ozawa, T., Fujita, T., & Uchida, K. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01138-3 · Cited by 32
New therapies for advanced glycation end product nephrotoxicity: Current challenges
Williams, M. E. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50083 · Cited by 30
Moreau, R. F., Nguyen, B. T., Doneanu, C. E., & Hagen, T. M. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.09.006 · Cited by 29
4-Hydroxy-2-nonenal as a COX-2 inducer
Uchida, K., & Kumagai, T. (2003) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(03)00016-5 · Cited by 29
Neely, M. D., Zimmerman, L. J., Picklo, M. J., Ou, J. J., Morales, C. R., Montine, K. S., Amaranth, V., & Montine, T. J. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00411-1 · Cited by 28
Antioxidant activity of a Schiff base of pyridoxal and aminoguanidine
Chen, A.-S., Taguchi, T., Aoyama, S., Sugiura, M., Haruna, M., Wang, M., & Miwa, I. (2003) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.08.014 · Cited by 28
Kuo, C.-L., Vaz, A. D. N., & Coon, M. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22611 · Cited by 25
Mechanism of Inhibition of Rat Liver Class 2 ALDH by 4-Hydroxynonenal
Luckey, S. W., Tjalkens, R. B., & Petersen, D. R. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4735-8_9 · Cited by 24
Culbertson, S. M., Enright, G. D., & Ingold, K. U. (2003) · Organic Letters · doi:10.1021/ol0348147 · Cited by 22
SAKURAI, T., Asakura, T., Mizuno, A., et al. (1991) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.37.341 · Cited by 22
Metformin inhibits monocyte adhesion to endothelial cells and foam cell formation
Mamputu, J., Wiernsperger, N. F., & Renier, G. (2003) · The British Journal of Diabetes · doi:10.1177/14746514030030041501 · Cited by 21
Inhibition of DNA methylase activity by acrolein
Cox, R., Goorha, S., & Irving, C. C. (1988) · Carcinogenesis · doi:10.1093/carcin/9.3.463 · Cited by 20
N -acetylcysteine therapy for Unverricht–Lundborg disease
Selwa, L. M. (1999) · Neurology · doi:10.1212/wnl.52.2.426 · Cited by 19
Nakamura, S., Tachikawa, T., Tobita, K., Aoyama, I., Takayama, F., Enomoto, A., & Niwa, T. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50088 · Cited by 18
Grace, J. M., Macdonald, T. L., Roberts, R. J., & Kinter, M. T. (1996) · Free Radical Research · doi:10.3109/10715769609145653 · Cited by 17
Reversible modification of arginine residues with glyoxal
Glass, J. D., & Pelzig, M. (1978) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(78)91566-8 · Cited by 16
Tardif, J., Grégoire, J. C., Lavoie, M.-A., & L’Allier, P. L. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200312000-00010 · Cited by 16
Patel, M. S., & Korotchkina, L. G. (2003) · Humana Press eBooks · doi:10.1385/1-59259-173-6:255 · Cited by 16
Carbonylated Proteins and Their Implication in Physiology and Pathology
Levine, R. L., & Stadtman, E. R. (2006) · Wiley eBooks · doi:10.1002/0471973122.ch5 · Cited by 15
Antioxidants and atherosclerosis: Emerging drug therapies
Tardif, J. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0078-1 · Cited by 15
Aminoguanidine prevents age‐related aortic stiffening in Fisher 344 rats: aortic impedance analysis
Chang, K., Hsu, K., Peng, Y., et al. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705410 · Cited by 13
Effect of 4‐hydroxy‐2(E)‐nonenal on soybean lipoxygenase‐1
Gardner, H. W., & Deighton, N. (2001) · Lipids · doi:10.1007/s11745-001-0766-9 · Cited by 13
Chang, K., Hsu, K., Chou, T., Lo, H., & Tseng, Y. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705831 · Cited by 13
Cited by
Tsikas, D. (2017) · Analytical Biochemistry · doi:10.1016/j.ab.2016.10.021 · Cited by 2,190
Maes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.004 · Cited by 1,140
Vistoli, G., De Maddis, D., Cipak, A., Zarkovic, N., Carini, M., & Aldini, G. (2013) · Free Radical Research · doi:10.3109/10715762.2013.815348 · Cited by 823
Self-citationTrevisani, M., Siemens, J., Materazzi, S., Bautista, D. M., Nassini, R., Campi, B., Imamachi, N., Andrè, E., Patacchini, R., Cottrell, G. S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705923104 · Cited by 770
Biomarkers of Oxidative Stress and Antioxidant Defense
Demirci-Çekiç, S., Özkan, G., Avan, A. N., Uzunboy, S., Çapanoğlu, E., & Apak, R. (2022) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2021.114477 · Cited by 587
Metadata
- Authors
- Aldini, G., Dalle‐Donne, I., Facino, R. M., Milzani, A., & Carini, M.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2006-10-16
- Volume
- 27
- Issue
- 6
- Pages
- 817-868
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W2949582036
- Cited by
- 289
- References
- 271
- FWCI
- 10.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.